BioPharma Credit (LSE:BPCR) Change In Payables And Accrued Expense : $0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Change In Payables And Accrued Expense?

BioPharma Credit's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was $0.0 Mil. It means BioPharma Credit's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Dec. 2024 .

BioPharma Credit's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was $0.0 Mil. It means BioPharma Credit's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

BioPharma Credit Change In Payables And Accrued Expense Historical Data

The historical data trend for BioPharma Credit's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Change In Payables And Accrued Expense Chart

BioPharma Credit Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

BioPharma Credit Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial											-	-	-	-	-

BioPharma Credit Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

BioPharma Credit Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Wellington Street, Central Square, Leeds, GBR, LS1 4DL

Website

https://www.bpcruk.com

BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit Headlines

No Headlines